About | Free Trial

Last Update

2008-03-17T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Background Information

Employment History

Chief Marketing Officer and Vice President Clinical Affairs
Genitope Corporation

Chief Med. Officer and Vice President
Genitope Corporation

Chief Medical Officer and Vice President of Medical Affairs
Genitope Corporation

Vice President of Oncology
Johnson & Johnson Pharmaceutical Research and Development

Various Research and Management Positions
Schering Plough Research Institute

Academic and Administrative Positions
University of Massachusetts Medical School

Education

M.D.

M.D

doctor of medicine degree

Harvard Medical School

Web References (26 Total References)


Genitope - Executive Management

www.genitope.com [cached]

Michael J. Buckley, Ph.D. | Thomas DeZao | Claude Miller | David Miller | Mary Ellen Rybak, M.D. | Thomas Theriault, Ph.D. | John Vuko | Laura Woodhead

...
Mary Ellen Rybak, M.D., Chief Medical Officer and Vice President of Medical Affairs
...
Mary Ellen Rybak, M.D.Chief Medical Officer and Vice President of Medical Affairs
Mary Ellen Rybak, M.D. has served as our Vice President of Medical Affairs since May 2006.Prior to joining Genitope Corporation, Dr. Rybak was Vice President of Oncology at Johnson & Johnson Pharmaceutical Research and Development (Johnson & Johnson PRD; formerly Janssen Research Foundation), where she oversaw the initial development of the company's therapeutic oncology unit.She has extensive experience in oncology clinical trial management and led the team that submitted Johnson & Johnson PRD's first NDA for an internally discovered new chemical entity.Previously, Dr. Rybak held various research and management positions at Schering Plough Research Institute (Union, New Jersey), and a number of academic and administrative positions at University of Massachusetts Medical School.


...

www.sec.gov [cached]

0001363053 Rybak Mary Ellen GENITOPE CORPORATION 6900 DUMBARTON CIRCLE FREMONT CA 94555-3651 0 1 0 0 CMO & VP Clinical Affairs


...

www.sec.gov [cached]

0001363053 Rybak Mary Ellen GENITOPE CORPORATION 525 PENOBSCOT DRIVE REDWOOD CITY CA 94403 0 1 0 0 Chief Med. Officer & VP


Genitope Corporation - Press Release

ir.genitope.com [cached]

REDWOOD CITY, Calif., May 16 /PRNewswire-FirstCall/ -- Genitope Corporation (Nasdaq: GTOP) today announced the appointment of Mary Rybak, M.D., as the company's vice president of medical affairs.Dr. Rybak will be responsible for working with Genitope's executive team to establish and execute the company's long-term clinical strategy for MyVax(R) personalized immunotherapy and other therapies in the company's research and development pipeline.

In this role, Dr. Rybak will be responsible for overseeing clinical research, the implementation of clinical trials, the interpretation of the results of investigations and medical information programs.
"I'm excited by the promise of MyVax(R) personalized immunotherapy, and impressed by the data that has been produced with this therapy.MyVax(R) personalized immunotherapy has tremendous potential to benefit patients and I look forward to exploring all clinical options to integrate it into treatment protocols for follicular Non-Hodgkin's Lymphoma and related cancers," said Dr. Rybak."I am also eager to move forward with prospects in the pipeline, such as the promising monoclonal antibody program.It's a great time to be at Genitope, and I'm thrilled to join the team."
Dr. Rybak has more than 15 years of management and leadership experience in the pharmaceutical industry.Prior to joining Genitope Corporation, Dr. Rybak was vice president of oncology at Johnson & Johnson Pharmaceutical Research and Development (Johnson & Johnson PRD; formerly Janssen Research Foundation), where she oversaw the initial development of the company's therapeutic oncology unit.She has extensive experience in oncology clinical trial management and led the team that submitted Johnson & Johnson PRD's first NDA for an internally discovered new chemical entity.Previously, Dr. Rybak held various research and management positions at Schering Plough Research Institute (Union, New Jersey), and a number of academic and administrative positions at University of Massachusetts Medical School.
Dr. Rybak earned her doctor of medicine degree from Harvard Medical School and conducted her internship and residency at Brigham and Women's Hospital in Boston, Massachusetts.
"We welcome Dr. Rybak to Genitope's management team.


Resident And Staff Physician

www.residentandstaff.com [cached]

/PRNewswire-FirstCall/ -- Genitope Corporation (Nasdaq: GTOP) today announced the appointment of Mary Rybak

, M.D., as the company's vice president of medical affairs.Dr. Rybak
will be responsible for working with Genitope's executive team to establish and execute the company's long-term clinical strategy for MyVax(R) personalized immunotherapy and other therapies in the company's research and development pipeline.
In this role, Dr. Rybak
will be responsible for overseeing clinical research, the implementation of clinical trials, the interpretation of the results of investigations and medical information programs.
"I'm excited by the promise of MyVax(R) personalized immunotherapy, and impressed by the data that has been produced with this therapy.MyVax(R) personalized immunotherapy has tremendous potential to benefit patients and I look forward to exploring all clinical options to integrate it into treatment protocols for follicular Non-Hodgkin's Lymphoma and related cancers," said Dr. Rybak
. "I am also eager to move forward with prospects in the pipeline, such as the promising monoclonal antibody program.It's a great time to be at Genitope, and I'm thrilled to join the team."
Dr. Rybak
has more than 15 years of management and leadership experience in the pharmaceutical industry.Prior to joining Genitope Corporation, Dr. Rybak
was vice president of oncology at Johnson & Johnson Pharmaceutical Research and Development (Johnson & Johnson PRD; formerly Janssen Research Foundation), where she oversaw the initial development of the company's therapeutic oncology unit.She has extensive experience in oncology clinical trial management and led the team that submitted Johnson & Johnson PRD's first NDA for an internally discovered new chemical entity.Previously, Dr. Rybak
held various research and management positions at Schering Plough Research Institute (Union, New Jersey), and a number of academic and administrative positions at University of Massachusetts Medical School.
Dr. Rybak
earned her doctor of medicine degree from Harvard Medical School and conducted her internship and residency at Brigham and Women's Hospital in Boston, Massachusetts.
"We welcome Dr. Rybak
to Genitope's management team.She brings a wealth of experience in all aspects of oncology drug development, including preclinical research, clinical trial design and FDA filings to commercialization and partnering.

Similar Profiles

Other People with this Name

Other people with the name Rybak

Malgorzata Rybak
Weber Shandwick Company

Lynn Rybak

Bob Rybak
Morguard Investments Limited

Alexandra Rybak
Urban Land Institute

John Rybak
Ukrainian American Citizens' Association

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory